{"id": "IEPA.d2.s2_IEPA.d2.s2.p1", "text": "SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16", "text_with_entity_marker": "SP ewes also had greater incorporation of [3H]inositol into [E1]inositol trisphosphate[/E1] (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to [E2]oxytocin[/E2], than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "inositol trisphosphate", "entity_1_idx": [[60, 82]], "entity_1_idx_in_text_with_entity_marker": [64, 86], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[192, 200]], "entity_2_idx_in_text_with_entity_marker": [205, 213], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d2.s2_IEPA.d2.s2.p6", "text": "SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16", "text_with_entity_marker": "SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total [E1]inositol phosphate[/E1] (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total [E2]IP[/E2], respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "inositol phosphate", "entity_1_idx": [[126, 144]], "entity_1_idx_in_text_with_entity_marker": [130, 148], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP", "entity_2_idx": [[255, 257]], "entity_2_idx_in_text_with_entity_marker": [268, 270], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d5.s9_IEPA.d5.s9.p0", "text": "Three experiments (Exp) assessed the influence of stage of the estrous cycle, pregnancy, and intrauterine infusion of ovine conceptus secretory proteins (oCSP) on turnover of inositol trisphosphate (the putative second-messenger for oxytocin-stimulated secretion of prostaglandin F2 alpha) in ovine endometrium during luteolysis and maternal recognition of pregnancy", "text_with_entity_marker": "Three experiments (Exp) assessed the influence of stage of the estrous cycle, pregnancy, and intrauterine infusion of ovine conceptus secretory proteins (oCSP) on turnover of [E1]inositol trisphosphate[/E1] (the putative second-messenger for [E2]oxytocin[/E2]-stimulated secretion of prostaglandin F2 alpha) in ovine endometrium during luteolysis and maternal recognition of pregnancy", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "inositol trisphosphate", "entity_1_idx": [[175, 197]], "entity_1_idx_in_text_with_entity_marker": [179, 201], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[233, 241]], "entity_2_idx_in_text_with_entity_marker": [246, 254], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d6.s11_IEPA.d6.s11.p0", "text": "Carbachol and oxytocin stimulate the generation of inositol phosphates in the guinea pig myometrium", "text_with_entity_marker": "Carbachol and [E1]oxytocin[/E1] stimulate the generation of [E2]inositol phosphates[/E2] in the guinea pig myometrium", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[14, 22]], "entity_1_idx_in_text_with_entity_marker": [18, 26], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "inositol phosphates", "entity_2_idx": [[51, 70]], "entity_2_idx_in_text_with_entity_marker": [64, 83], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d9.s21_IEPA.d9.s21.p0", "text": "U-73122 (3 microM) also abolished the OT-induced IP3 formation", "text_with_entity_marker": "U-73122 (3 microM) also abolished the [E1]OT[/E1]-induced [E2]IP3[/E2] formation", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "OT", "entity_1_idx": [[38, 40]], "entity_1_idx_in_text_with_entity_marker": [42, 44], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[49, 52]], "entity_2_idx_in_text_with_entity_marker": [62, 65], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d11.s23_IEPA.d11.s23.p0", "text": "Amyloid beta protein (25-35) stimulation of phospholipases A, C and D activities of LA-N-2 cells", "text_with_entity_marker": "[E1]Amyloid[/E1] beta protein (25-35) stimulation of [E2]phospholipases[/E2] A, C and D activities of LA-N-2 cells", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Amyloid", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipases", "entity_2_idx": [[44, 58]], "entity_2_idx_in_text_with_entity_marker": [57, 71], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d11.s24_IEPA.d11.s24.p0", "text": "[3H]Inositol prelabeled LA-N-2 cells were exposed to varying concentrations of A beta P, from 20 to 125 micrograms/ml, and phospholipase C activation was measured", "text_with_entity_marker": "[3H]Inositol prelabeled LA-N-2 cells were exposed to varying concentrations of [E1]A beta P[/E1], from 20 to 125 micrograms/ml, and [E2]phospholipase C[/E2] activation was measured", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "A beta P", "entity_1_idx": [[79, 87]], "entity_1_idx_in_text_with_entity_marker": [83, 91], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[123, 138]], "entity_2_idx_in_text_with_entity_marker": [136, 151], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d11.s25_IEPA.d11.s25.p0", "text": "The effects of adrenergic, metabotropic amino acid and bombesin antagonists on the A beta P mediated stimulation of phospholipase C activity was investigated", "text_with_entity_marker": "The effects of adrenergic, metabotropic amino acid and bombesin antagonists on the [E1]A beta P[/E1] mediated stimulation of [E2]phospholipase C[/E2] activity was investigated", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "A beta P", "entity_1_idx": [[83, 91]], "entity_1_idx_in_text_with_entity_marker": [87, 95], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[116, 131]], "entity_2_idx_in_text_with_entity_marker": [129, 144], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d11.s26_IEPA.d11.s26.p0", "text": "Propranolol, a beta adrenergic antagonist, 7-chloro-kynurenic acid, a metabotropic amino acid antagonist, and [Tyr4-D-Phe12]bombesin, a bombesin antagonist, blunted the A beta P stimulation of phospholipase C activity in [3H]inositol prelabeled LA-N-2 cells", "text_with_entity_marker": "Propranolol, a beta adrenergic antagonist, 7-chloro-kynurenic acid, a metabotropic amino acid antagonist, and [Tyr4-D-Phe12]bombesin, a bombesin antagonist, blunted the [E1]A beta P[/E1] stimulation of [E2]phospholipase C[/E2] activity in [3H]inositol prelabeled LA-N-2 cells", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "A beta P", "entity_1_idx": [[169, 177]], "entity_1_idx_in_text_with_entity_marker": [173, 181], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[193, 208]], "entity_2_idx_in_text_with_entity_marker": [206, 221], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d28.s60_IEPA.d28.s60.p1", "text": "In HVSMC both oxytocin and AVP increased inositol 1,4,5-trisphosphate (IP3) production and [Ca2+]i response, but the efficacy of the responses was greater for oxytocin than AVP", "text_with_entity_marker": "In HVSMC both [E1]oxytocin[/E1] and AVP increased inositol 1,4,5-trisphosphate (IP3) production and [Ca2+]i response, but the efficacy of the responses was greater for [E2]oxytocin[/E2] than AVP", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[14, 22]], "entity_1_idx_in_text_with_entity_marker": [18, 26], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[159, 167]], "entity_2_idx_in_text_with_entity_marker": [172, 180], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d33.s76_IEPA.d33.s76.p0", "text": "Thereafter, the stimulatory effects of OT on IPs formation and the OT receptor levels dramatically increased toward the end of pregnancy and reduced rapidly after parturition", "text_with_entity_marker": "Thereafter, the stimulatory effects of [E1]OT[/E1] on [E2]IPs[/E2] formation and the OT receptor levels dramatically increased toward the end of pregnancy and reduced rapidly after parturition", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "OT", "entity_1_idx": [[39, 41]], "entity_1_idx_in_text_with_entity_marker": [43, 45], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IPs", "entity_2_idx": [[45, 48]], "entity_2_idx_in_text_with_entity_marker": [58, 61], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d33.s79_IEPA.d33.s79.p0", "text": "CONCLUSIONS: These results suggest that the formation of IPs by OT, the OT receptor levels in the myometrium, and the production of PGF2 in the decidua might play crucial roles in parturition", "text_with_entity_marker": "CONCLUSIONS: These results suggest that the formation of [E1]IPs[/E1] by [E2]OT[/E2], the OT receptor levels in the myometrium, and the production of PGF2 in the decidua might play crucial roles in parturition", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "IPs", "entity_1_idx": [[57, 60]], "entity_1_idx_in_text_with_entity_marker": [61, 64], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "OT", "entity_2_idx": [[64, 66]], "entity_2_idx_in_text_with_entity_marker": [77, 79], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d36.s88_IEPA.d36.s88.p1", "text": "The present studies compared the effects of insulin in rat adipocytes with the effects of oxytocin and peroxovanadate, which mimic some effects of insulin", "text_with_entity_marker": "The present studies compared the effects of [E1]insulin[/E1] in rat adipocytes with the effects of oxytocin and peroxovanadate, which mimic some effects of [E2]insulin[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[44, 51]], "entity_1_idx_in_text_with_entity_marker": [48, 55], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[147, 154]], "entity_2_idx_in_text_with_entity_marker": [160, 167], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d37.s91_IEPA.d37.s91.p0", "text": "These findings support the concept that the mitochondrial metabolism of nutrient molecules is an event sufficient to acutely augment insulin release from the beta cell, to increase phospholipase C-mediated phosphoinositide hydrolysis, and to induce time-dependent potentiation of insulin secretion", "text_with_entity_marker": "These findings support the concept that the mitochondrial metabolism of nutrient molecules is an event sufficient to acutely augment [E1]insulin[/E1] release from the beta cell, to increase [E2]phospholipase C[/E2]-mediated phosphoinositide hydrolysis, and to induce time-dependent potentiation of insulin secretion", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[133, 140]], "entity_1_idx_in_text_with_entity_marker": [137, 144], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[181, 196]], "entity_2_idx_in_text_with_entity_marker": [194, 209], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d39.s95_IEPA.d39.s95.p1", "text": "Both p-nitrophenylphosphatidylcholine hydrolytic activity and liposome lytic activity of insulin-phospholipase C conjugate were inhibited in the presence of insulin antiserum", "text_with_entity_marker": "Both p-nitrophenylphosphatidylcholine hydrolytic activity and liposome lytic activity of [E1]insulin[/E1]-phospholipase C conjugate were inhibited in the presence of [E2]insulin[/E2] antiserum", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[89, 96]], "entity_1_idx_in_text_with_entity_marker": [93, 100], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[157, 164]], "entity_2_idx_in_text_with_entity_marker": [170, 177], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d40.s99_IEPA.d40.s99.p5", "text": "These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced insulin secretion in primed islets but that PLC activation can clearly be dissociated from insulin secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced insulin secretion", "text_with_entity_marker": "These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced insulin secretion in primed islets but that PLC activation can clearly be dissociated from [E1]insulin[/E1] secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced [E2]insulin[/E2] secretion", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[198, 205]], "entity_1_idx_in_text_with_entity_marker": [202, 209], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[300, 307]], "entity_2_idx_in_text_with_entity_marker": [313, 320], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d42.s104_IEPA.d42.s104.p0", "text": "The physiologic regulation of glucose-induced insulin secretion is dependent upon the activation of information flow in the phospholipase C (PLC)/protein kinase C (PKC) signal transduction system", "text_with_entity_marker": "The physiologic regulation of glucose-induced [E1]insulin[/E1] secretion is dependent upon the activation of information flow in the [E2]phospholipase C[/E2] (PLC)/protein kinase C (PKC) signal transduction system", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[46, 53]], "entity_1_idx_in_text_with_entity_marker": [50, 57], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[124, 139]], "entity_2_idx_in_text_with_entity_marker": [137, 152], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d45.s114_IEPA.d45.s114.p0", "text": "Cellular preincubation with 200 microg/ml antibodies against the inositolphosphoglycan (IPG) moiety of the GPI-anchor (Ab(IPG)), or depletion in GPI-anchored proteins by cellular pretreatment with 0.5 U/ml PI-PLC, 1 mM insulin and 2 HU/ml streptolysin-O, or depletion in membrane cholesterol content by filipin (5 microg/ml), digitonin (5 microg/ml) and cholesterol oxidase (0.5 U/ml) decreases the HDL3-signal, suggesting the involvement of a lipolytic cleavage of GPI-anchored proteins", "text_with_entity_marker": "Cellular preincubation with 200 microg/ml antibodies against the inositolphosphoglycan (IPG) moiety of the GPI-anchor (Ab(IPG)), or depletion in GPI-anchored proteins by cellular pretreatment with 0.5 U/ml PI-[E1]PLC[/E1], 1 mM [E2]insulin[/E2] and 2 HU/ml streptolysin-O, or depletion in membrane cholesterol content by filipin (5 microg/ml), digitonin (5 microg/ml) and cholesterol oxidase (0.5 U/ml) decreases the HDL3-signal, suggesting the involvement of a lipolytic cleavage of GPI-anchored proteins", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC", "entity_1_idx": [[209, 212]], "entity_1_idx_in_text_with_entity_marker": [213, 216], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d46.s118_IEPA.d46.s118.p1", "text": "Amyloid beta protein stimulation of phospholipase C was absent from LA-N-2 cells previously treated with norepinephrine, trans-1-amino-1,3-cyclopentanedicarboxylic acid (t-ACPD), bombesin, or amyloid beta peptide", "text_with_entity_marker": "[E1]Amyloid[/E1] beta protein stimulation of phospholipase C was absent from LA-N-2 cells previously treated with norepinephrine, trans-1-amino-1,3-cyclopentanedicarboxylic acid (t-ACPD), bombesin, or [E2]amyloid[/E2] beta peptide", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Amyloid", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "amyloid", "entity_2_idx": [[192, 199]], "entity_2_idx_in_text_with_entity_marker": [205, 212], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d47.s121_IEPA.d47.s121.p0", "text": "The effects of the posterior-pituitary peptides oxytocin (OT), arginine-vasopressin (AVP) and lysine-vasopressin (LVP) on insulin and glucagon secretion were examined in adult sheep", "text_with_entity_marker": "The effects of the posterior-pituitary peptides [E1]oxytocin[/E1] (OT), arginine-vasopressin (AVP) and lysine-vasopressin (LVP) on [E2]insulin[/E2] and glucagon secretion were examined in adult sheep", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[48, 56]], "entity_1_idx_in_text_with_entity_marker": [52, 60], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[122, 129]], "entity_2_idx_in_text_with_entity_marker": [135, 142], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d47.s122_IEPA.d47.s122.p5", "text": "The maximal insulin responses induced by OT and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma insulin were higher than those of OT", "text_with_entity_marker": "The maximal insulin responses induced by OT and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma [E1]insulin[/E1] were higher than those of [E2]OT[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[136, 143]], "entity_1_idx_in_text_with_entity_marker": [140, 147], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "OT", "entity_2_idx": [[170, 172]], "entity_2_idx_in_text_with_entity_marker": [183, 185], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d50.s127_IEPA.d50.s127.p2", "text": "Insulin secretion is regulated by changes in blood glucose, as well as by peptides from the gastrointestinal tract and neurotransmitters that activate the pancreatic islet adenylyl cyclase (e.g., glucagon-like peptide-1) and phospholipase C (PLC) (e.g., acetylcholine) signaling pathways to further potentiate glucose-induced insulin secretion", "text_with_entity_marker": "Insulin secretion is regulated by changes in blood glucose, as well as by peptides from the gastrointestinal tract and neurotransmitters that activate the pancreatic islet adenylyl cyclase (e.g., glucagon-like peptide-1) and [E1]phospholipase C[/E1] (PLC) (e.g., acetylcholine) signaling pathways to further potentiate glucose-induced [E2]insulin[/E2] secretion", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phospholipase C", "entity_1_idx": [[225, 240]], "entity_1_idx_in_text_with_entity_marker": [229, 244], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[326, 333]], "entity_2_idx_in_text_with_entity_marker": [339, 346], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d58.s151_IEPA.d58.s151.p1", "text": "In these cells, AVP also causes the translocation of PKC from the cytosol to the cell membrane which is maximal at 5 min, but the intracellular events distal to protein kinase C activation that underlie ACTH secretion have not been well characterized to date", "text_with_entity_marker": "In these cells, [E1]AVP[/E1] also causes the translocation of PKC from the cytosol to the cell membrane which is maximal at 5 min, but the intracellular events distal to [E2]protein kinase C[/E2] activation that underlie ACTH secretion have not been well characterized to date", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AVP", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[161, 177]], "entity_2_idx_in_text_with_entity_marker": [174, 190], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d58.s153_IEPA.d58.s153.p5", "text": "We conclude that: (1) AVP causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the AVP-induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PKC trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PKC activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.", "text_with_entity_marker": "We conclude that: (1) AVP causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the AVP-induced increase in MARCKS phosphorylation occurs much earlier in these cells than does [E1]PKC[/E1] trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of [E2]PKC[/E2] activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC", "entity_1_idx": [[235, 238]], "entity_1_idx_in_text_with_entity_marker": [239, 242], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[329, 332]], "entity_2_idx_in_text_with_entity_marker": [342, 345], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d69.s170_IEPA.d69.s170.p0", "text": "During wk 6, milk yield and dry matter intake (DMI) were recorded daily, and plasma concentrations of glucose, nonesterified fatty acids, urea, protein, growth hormone, insulin, insulin-like growth factor I, oxytocin, and prolactin were determined", "text_with_entity_marker": "During wk 6, milk yield and dry matter intake (DMI) were recorded daily, and plasma concentrations of glucose, nonesterified fatty acids, urea, protein, growth hormone, [E1]insulin[/E1], insulin-like growth factor I, [E2]oxytocin[/E2], and prolactin were determined", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[169, 176]], "entity_1_idx_in_text_with_entity_marker": [173, 180], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[208, 216]], "entity_2_idx_in_text_with_entity_marker": [221, 229], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d74.s178_IEPA.d74.s178.p3", "text": "While leptin maintains or favors energy-dissipating mechanisms (UCP1, UCP2, and UCP3), the latter are markedly depressed in pair-fed rats", "text_with_entity_marker": "While leptin maintains or favors energy-dissipating mechanisms ([E1]UCP1[/E1], [E2]UCP2[/E2], and UCP3), the latter are markedly depressed in pair-fed rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP1", "entity_1_idx": [[64, 68]], "entity_1_idx_in_text_with_entity_marker": [68, 72], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[70, 74]], "entity_2_idx_in_text_with_entity_marker": [83, 87], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d75.s180_IEPA.d75.s180.p0", "text": "Mean numbers of AVP- and protein kinase Calpha-immunoreactive neurons were determined in the suprachiasmatic nucleus of common voles, entrained to a 12:12 h light-dark (LD) cycle, at the beginning of the light period (zeitgeber time zero) and 6 h later (zeitgeber time six)", "text_with_entity_marker": "Mean numbers of [E1]AVP[/E1]- and [E2]protein kinase Calpha[/E2]-immunoreactive neurons were determined in the suprachiasmatic nucleus of common voles, entrained to a 12:12 h light-dark (LD) cycle, at the beginning of the light period (zeitgeber time zero) and 6 h later (zeitgeber time six)", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AVP", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase Calpha", "entity_2_idx": [[25, 46]], "entity_2_idx_in_text_with_entity_marker": [38, 59], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d75.s181_IEPA.d75.s181.p0", "text": "At zeitgeber time zero, mean numbers of AVP- and protein kinase Calpha- immunoreactive neurons were 2194 and 9897, respectively", "text_with_entity_marker": "At zeitgeber time zero, mean numbers of [E1]AVP[/E1]- and [E2]protein kinase Calpha[/E2]- immunoreactive neurons were 2194 and 9897, respectively", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AVP", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase Calpha", "entity_2_idx": [[49, 70]], "entity_2_idx_in_text_with_entity_marker": [62, 83], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d78.s188_IEPA.d78.s188.p0", "text": "These results confirm that AVP and PMA activate PKC and indicate that IL-1 likely does not activate PKC in Leydig cells", "text_with_entity_marker": "These results confirm that [E1]AVP[/E1] and PMA activate [E2]PKC[/E2] and indicate that IL-1 likely does not activate PKC in Leydig cells", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AVP", "entity_1_idx": [[27, 30]], "entity_1_idx_in_text_with_entity_marker": [31, 34], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[48, 51]], "entity_2_idx_in_text_with_entity_marker": [61, 64], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d84.s200_IEPA.d84.s200.p0", "text": "Since previous studies showed that AVP secretion is influenced by the persistence of residual endogenous insulin secretion, we wondered whether this factor also regulates OT secretion", "text_with_entity_marker": "Since previous studies showed that AVP secretion is influenced by the persistence of residual endogenous [E1]insulin[/E1] secretion, we wondered whether this factor also regulates [E2]OT[/E2] secretion", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[105, 112]], "entity_1_idx_in_text_with_entity_marker": [109, 116], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "OT", "entity_2_idx": [[171, 173]], "entity_2_idx_in_text_with_entity_marker": [184, 186], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d84.s201_IEPA.d84.s201.p1", "text": "DESIGN: Case-control study: the OT response to insulin-induced hypoglycaemia was measured in normal and diabetic patients with or without residual endogenous insulin secretion", "text_with_entity_marker": "DESIGN: Case-control study: the [E1]OT[/E1] response to insulin-induced hypoglycaemia was measured in normal and diabetic patients with or without residual endogenous [E2]insulin[/E2] secretion", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "OT", "entity_1_idx": [[32, 34]], "entity_1_idx_in_text_with_entity_marker": [36, 38], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[158, 165]], "entity_2_idx_in_text_with_entity_marker": [171, 178], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d84.s201_IEPA.d84.s201.p2", "text": "DESIGN: Case-control study: the OT response to insulin-induced hypoglycaemia was measured in normal and diabetic patients with or without residual endogenous insulin secretion", "text_with_entity_marker": "DESIGN: Case-control study: the OT response to [E1]insulin[/E1]-induced hypoglycaemia was measured in normal and diabetic patients with or without residual endogenous [E2]insulin[/E2] secretion", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[47, 54]], "entity_1_idx_in_text_with_entity_marker": [51, 58], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[158, 165]], "entity_2_idx_in_text_with_entity_marker": [171, 178], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p3", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of [E1]UCP3[/E1] and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and [E2]UCP2[/E2] in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP3", "entity_1_idx": [[50, 54]], "entity_1_idx_in_text_with_entity_marker": [54, 58], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[373, 377]], "entity_2_idx_in_text_with_entity_marker": [386, 390], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p8", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with [E1]leptin[/E1] receptor defect, and investigated expression of the genes encoding UCP3 and [E2]UCP2[/E2] in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[290, 296]], "entity_1_idx_in_text_with_entity_marker": [294, 300], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[373, 377]], "entity_2_idx_in_text_with_entity_marker": [386, 390], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d104.s243_IEPA.d104.s243.p0", "text": "In addition, abscisic acid-mediated inhibition of gibberellin-stimulated responses seems to depend on the activation of a phospholipase D during induction of alpha-amylase in barley aleurone cells as well as on a putative acetyltransferase involved in elongation growth.", "text_with_entity_marker": "In addition, abscisic acid-mediated inhibition of [E1]gibberellin[/E1]-stimulated responses seems to depend on the activation of a phospholipase D during induction of [E2]alpha-amylase[/E2] in barley aleurone cells as well as on a putative acetyltransferase involved in elongation growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gibberellin", "entity_1_idx": [[50, 61]], "entity_1_idx_in_text_with_entity_marker": [54, 65], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[158, 171]], "entity_2_idx_in_text_with_entity_marker": [171, 184], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d106.s245_IEPA.d106.s245.p1", "text": "Protein kinase C (PKC) inhibitors reversed AVP inhibition, whereas PKC activator inhibited nitrite production", "text_with_entity_marker": "[E1]Protein kinase C[/E1] (PKC) inhibitors reversed AVP inhibition, whereas [E2]PKC[/E2] activator inhibited nitrite production", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Protein kinase C", "entity_1_idx": [[0, 16]], "entity_1_idx_in_text_with_entity_marker": [4, 20], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[67, 70]], "entity_2_idx_in_text_with_entity_marker": [80, 83], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d106.s246_IEPA.d106.s246.p0", "text": "The inhibitory action of AVP involves both the activation of PKC and the transcription of iNOS mRNA in cultured rat GMC", "text_with_entity_marker": "The inhibitory action of [E1]AVP[/E1] involves both the activation of [E2]PKC[/E2] and the transcription of iNOS mRNA in cultured rat GMC", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AVP", "entity_1_idx": [[25, 28]], "entity_1_idx_in_text_with_entity_marker": [29, 32], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[61, 64]], "entity_2_idx_in_text_with_entity_marker": [74, 77], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d108.s254_IEPA.d108.s254.p2", "text": "When the alpha2-adrenoreceptor agonist clonidine (2.5 microgram/kg intracerebroventricularly) was administered 3 days after the 5-day treatment period with oxytocin or saline, plasma levels of insulin and CCK increased significantly (p < 0.05) in the oxytocin-treated rats, when compared to saline-treated controls receiving clonidine only", "text_with_entity_marker": "When the alpha2-adrenoreceptor agonist clonidine (2.5 microgram/kg intracerebroventricularly) was administered 3 days after the 5-day treatment period with oxytocin or saline, plasma levels of [E1]insulin[/E1] and CCK increased significantly (p < 0.05) in the [E2]oxytocin[/E2]-treated rats, when compared to saline-treated controls receiving clonidine only", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[193, 200]], "entity_1_idx_in_text_with_entity_marker": [197, 204], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[251, 259]], "entity_2_idx_in_text_with_entity_marker": [264, 272], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d108.s255_IEPA.d108.s255.p0", "text": "In conclusion, these results show that oxytocin induces long-lasting changes in plasma levels of gastrin, CCK and insulin, without affecting somatostatin or glucose levels", "text_with_entity_marker": "In conclusion, these results show that [E1]oxytocin[/E1] induces long-lasting changes in plasma levels of gastrin, CCK and [E2]insulin[/E2], without affecting somatostatin or glucose levels", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[114, 121]], "entity_2_idx_in_text_with_entity_marker": [127, 134], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s258_IEPA.d109.s258.p0", "text": "Leptin, compared with vehicle, did not alter BAT UCP-1 or UCP-3 mRNA or protein expression when administered to normal ad libitum fed rats", "text_with_entity_marker": "[E1]Leptin[/E1], compared with vehicle, did not alter BAT [E2]UCP-1[/E2] or UCP-3 mRNA or protein expression when administered to normal ad libitum fed rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-1", "entity_2_idx": [[49, 54]], "entity_2_idx_in_text_with_entity_marker": [62, 67], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s258_IEPA.d109.s258.p2", "text": "Leptin, compared with vehicle, did not alter BAT UCP-1 or UCP-3 mRNA or protein expression when administered to normal ad libitum fed rats", "text_with_entity_marker": "Leptin, compared with vehicle, did not alter BAT [E1]UCP-1[/E1] or [E2]UCP-3[/E2] mRNA or protein expression when administered to normal ad libitum fed rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP-1", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s261_IEPA.d109.s261.p3", "text": "Fasting, with or without leptin administration, did not affect BAT UCP-2 mRNA; however, leptin administration to ad libitum fed rats significantly increased BAT UCP-2 mRNA, to 138% of control", "text_with_entity_marker": "Fasting, with or without leptin administration, did not affect BAT [E1]UCP-2[/E1] mRNA; however, [E2]leptin[/E2] administration to ad libitum fed rats significantly increased BAT UCP-2 mRNA, to 138% of control", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP-2", "entity_1_idx": [[67, 72]], "entity_1_idx_in_text_with_entity_marker": [71, 76], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[88, 94]], "entity_2_idx_in_text_with_entity_marker": [101, 107], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d114.s275_IEPA.d114.s275.p0", "text": "To determine whether UCP-2 does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in leptin-unresponsive UCP-2-underexpressing islets of diabetic ZDF rats, we transferred the UCP-2 gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats", "text_with_entity_marker": "To determine whether [E1]UCP-2[/E1] does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in [E2]leptin[/E2]-unresponsive UCP-2-underexpressing islets of diabetic ZDF rats, we transferred the UCP-2 gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP-2", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[148, 154]], "entity_2_idx_in_text_with_entity_marker": [161, 167], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d115.s280_IEPA.d115.s280.p0", "text": "Adenovirus-mediated overexpression of PLC-delta1, -beta1, or  -beta3 in INS-1 or betaG 40/110 cells results in little or no enhancement  in inositol phosphate (IP) accumulation and no improvement in insulin  secretion when the cells are stimulated with glucose or carbachol, despite  the fact that the overexpressed proteins are fully active in cell  extracts.", "text_with_entity_marker": "Adenovirus-mediated overexpression of [E1]PLC[/E1]-delta1, -beta1, or  -beta3 in INS-1 or betaG 40/110 cells results in little or no enhancement  in inositol phosphate (IP) accumulation and no improvement in [E2]insulin[/E2]  secretion when the cells are stimulated with glucose or carbachol, despite  the fact that the overexpressed proteins are fully active in cell  extracts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC", "entity_1_idx": [[38, 41]], "entity_1_idx_in_text_with_entity_marker": [42, 45], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[199, 206]], "entity_2_idx_in_text_with_entity_marker": [212, 219], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d115.s282_IEPA.d115.s282.p0", "text": "Because the effect of carbachol on insulin secretion is  thought to be mediated through muscarinic receptors that link to the Gq/11  class of heterotrimeric G proteins, we also overexpressed G11alpha in  INS-1 cells, either alone or in concert with overexpression of PLC-beta1  or -beta3.", "text_with_entity_marker": "Because the effect of carbachol on [E1]insulin[/E1] secretion is  thought to be mediated through muscarinic receptors that link to the Gq/11  class of heterotrimeric G proteins, we also overexpressed G11alpha in  INS-1 cells, either alone or in concert with overexpression of [E2]PLC[/E2]-beta1  or -beta3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[35, 42]], "entity_1_idx_in_text_with_entity_marker": [39, 46], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[267, 270]], "entity_2_idx_in_text_with_entity_marker": [280, 283], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d117.s285_IEPA.d117.s285.p3", "text": "The second class of mutant, gse (GA sensitivity), differed principally in GA sensitivity, requiring approximately 100-fold higher [GA3] for both leaf elongation and alpha-amylase production by aleurone", "text_with_entity_marker": "The second class of mutant, gse (GA sensitivity), differed principally in [E1]GA[/E1] sensitivity, requiring approximately 100-fold higher [[E2]GA3[/E2]] for both leaf elongation and alpha-amylase production by aleurone", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GA", "entity_1_idx": [[74, 76]], "entity_1_idx_in_text_with_entity_marker": [78, 80], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GA3", "entity_2_idx": [[131, 134]], "entity_2_idx_in_text_with_entity_marker": [144, 147], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d125.s298_IEPA.d125.s298.p0", "text": "Our data demonstrate, that activation of mitogen activated protein (MAP) kinase alone is sufficient to promote APP secretion, whereas inhibition of MAP kinase will reduce APP secretion only when phospholipase Cgamma or phosphatidylinositol 3-kinase are additionally inhibited", "text_with_entity_marker": "Our data demonstrate, that activation of mitogen activated protein (MAP) kinase alone is sufficient to promote [E1]APP[/E1] secretion, whereas inhibition of MAP kinase will reduce [E2]APP[/E2] secretion only when phospholipase Cgamma or phosphatidylinositol 3-kinase are additionally inhibited", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "APP", "entity_1_idx": [[111, 114]], "entity_1_idx_in_text_with_entity_marker": [115, 118], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "APP", "entity_2_idx": [[171, 174]], "entity_2_idx_in_text_with_entity_marker": [184, 187], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s299_IEPA.d126.s299.p5", "text": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels", "text_with_entity_marker": "The expression of uterine UCP2 and [E1]UCP3[/E1] were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT [E2]leptin[/E2] mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP3", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[153, 159]], "entity_2_idx_in_text_with_entity_marker": [166, 172], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s300_IEPA.d126.s300.p3", "text": "These results indicate that UCP gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine UCP2 and UCP3 mRNA may be due to increased leptin levels", "text_with_entity_marker": "These results indicate that UCP gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine [E1]UCP2[/E1] and [E2]UCP3[/E2] mRNA may be due to increased leptin levels", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP2", "entity_1_idx": [[129, 133]], "entity_1_idx_in_text_with_entity_marker": [133, 137], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s300_IEPA.d126.s300.p4", "text": "These results indicate that UCP gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine UCP2 and UCP3 mRNA may be due to increased leptin levels", "text_with_entity_marker": "These results indicate that UCP gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine [E1]UCP2[/E1] and UCP3 mRNA may be due to increased [E2]leptin[/E2] levels", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UCP2", "entity_1_idx": [[129, 133]], "entity_1_idx_in_text_with_entity_marker": [133, 137], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[172, 178]], "entity_2_idx_in_text_with_entity_marker": [185, 191], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d130.s314_IEPA.d130.s314.p2", "text": "Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and PIP2-PLC", "text_with_entity_marker": "Moreover, [E1]A beta[/E1] 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and [E2]PIP2-PLC[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "A beta", "entity_1_idx": [[10, 16]], "entity_1_idx_in_text_with_entity_marker": [14, 20], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PIP2-PLC", "entity_2_idx": [[89, 97]], "entity_2_idx_in_text_with_entity_marker": [102, 110], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d133.s321_IEPA.d133.s321.p0", "text": "Neurotransmitters and hormones, such as arginine vasopressin (AVP) and bombesin, evoke frequency-modulated repetitive Ca2+ transients in insulin-secreting HIT-T15 cells by binding to receptors linked to phospholipase C (PLC)", "text_with_entity_marker": "Neurotransmitters and hormones, such as arginine vasopressin (AVP) and bombesin, evoke frequency-modulated repetitive Ca2+ transients in [E1]insulin[/E1]-secreting HIT-T15 cells by binding to receptors linked to [E2]phospholipase C[/E2] (PLC)", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[137, 144]], "entity_1_idx_in_text_with_entity_marker": [141, 148], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[203, 218]], "entity_2_idx_in_text_with_entity_marker": [216, 231], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d138.s327_IEPA.d138.s327.p0", "text": "Insulin-like signaling in yeast: modulation of protein phosphatase 2A, protein kinase A, cAMP-specific phosphodiesterase, and glycosyl-phosphatidylinositol-specific phospholipase C activities", "text_with_entity_marker": "[E1]Insulin[/E1]-like signaling in yeast: modulation of protein phosphatase 2A, protein kinase A, cAMP-specific phosphodiesterase, and glycosyl-phosphatidylinositol-specific [E2]phospholipase C[/E2] activities", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Insulin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[165, 180]], "entity_2_idx_in_text_with_entity_marker": [178, 193], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d139.s334_IEPA.d139.s334.p3", "text": "A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma leptin and WAT leptin expression", "text_with_entity_marker": "A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle [E1]UCP2[/E1] expression, as well as for plasma [E2]leptin[/E2] and WAT leptin expression", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP2", "entity_1_idx": [[383, 387]], "entity_1_idx_in_text_with_entity_marker": [387, 391], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[422, 428]], "entity_2_idx_in_text_with_entity_marker": [435, 441], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d141.s339_IEPA.d141.s339.p0", "text": "We examined whether tolbutamide and diazoxide, which close or open ATP-sensitive K(+) channels (K(ATP) channels), respectively, interact with PLC-linked Ca(2+) signals in HIT-T15 and mouse beta-cells and with PLC-linked insulin secretion from HIT-T15 cells", "text_with_entity_marker": "We examined whether tolbutamide and diazoxide, which close or open ATP-sensitive K(+) channels (K(ATP) channels), respectively, interact with [E1]PLC[/E1]-linked Ca(2+) signals in HIT-T15 and mouse beta-cells and with [E2]PLC[/E2]-linked insulin secretion from HIT-T15 cells", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC", "entity_1_idx": [[142, 145]], "entity_1_idx_in_text_with_entity_marker": [146, 149], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[209, 212]], "entity_2_idx_in_text_with_entity_marker": [222, 225], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d141.s339_IEPA.d141.s339.p2", "text": "We examined whether tolbutamide and diazoxide, which close or open ATP-sensitive K(+) channels (K(ATP) channels), respectively, interact with PLC-linked Ca(2+) signals in HIT-T15 and mouse beta-cells and with PLC-linked insulin secretion from HIT-T15 cells", "text_with_entity_marker": "We examined whether tolbutamide and diazoxide, which close or open ATP-sensitive K(+) channels (K(ATP) channels), respectively, interact with PLC-linked Ca(2+) signals in HIT-T15 and mouse beta-cells and with [E1]PLC[/E1]-linked [E2]insulin[/E2] secretion from HIT-T15 cells", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PLC", "entity_1_idx": [[209, 212]], "entity_1_idx_in_text_with_entity_marker": [213, 216], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[220, 227]], "entity_2_idx_in_text_with_entity_marker": [233, 240], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d144.s345_IEPA.d144.s345.p0", "text": "Hypothalamic neuropeptide Y and its neuroendocrine regulation by leptin", "text_with_entity_marker": "Hypothalamic [E1]neuropeptide Y[/E1] and its neuroendocrine regulation by [E2]leptin[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "neuropeptide Y", "entity_1_idx": [[13, 27]], "entity_1_idx_in_text_with_entity_marker": [17, 31], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[65, 71]], "entity_2_idx_in_text_with_entity_marker": [78, 84], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d145.s349_IEPA.d145.s349.p0", "text": "This additionally supports the inhibitory effect of A(beta) on membrane-bound and cytosolic PLC", "text_with_entity_marker": "This additionally supports the inhibitory effect of [E1]A(beta)[/E1] on membrane-bound and cytosolic [E2]PLC[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "A(beta)", "entity_1_idx": [[52, 59]], "entity_1_idx_in_text_with_entity_marker": [56, 63], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[92, 95]], "entity_2_idx_in_text_with_entity_marker": [105, 108], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d145.s350_IEPA.d145.s350.p0", "text": "Moreover, A(beta) (1-40) significantly decreased the basal activity of the PIP2-PLC in SPM and the enzyme activity regulated through cholinergic receptors", "text_with_entity_marker": "Moreover, [E1]A(beta) (1-40)[/E1] significantly decreased the basal activity of the [E2]PIP2-PLC[/E2] in SPM and the enzyme activity regulated through cholinergic receptors", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "A(beta) (1-40)", "entity_1_idx": [[10, 24]], "entity_1_idx_in_text_with_entity_marker": [14, 28], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PIP2-PLC", "entity_2_idx": [[75, 83]], "entity_2_idx_in_text_with_entity_marker": [88, 96], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d147.s358_IEPA.d147.s358.p0", "text": "With regard to CK2, phosphorylation occurs at Ser 154 with a stoichiometry of about 0.1 mol phosphate/mol rbPrP, which is doubled by mild heat treatment of rbPrP", "text_with_entity_marker": "With regard to [E1]CK2[/E1], phosphorylation occurs at Ser 154 with a stoichiometry of about 0.1 mol phosphate/mol [E2]rbPrP[/E2], which is doubled by mild heat treatment of rbPrP", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CK2", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "rbPrP", "entity_2_idx": [[106, 111]], "entity_2_idx_in_text_with_entity_marker": [119, 124], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d147.s358_IEPA.d147.s358.p1", "text": "With regard to CK2, phosphorylation occurs at Ser 154 with a stoichiometry of about 0.1 mol phosphate/mol rbPrP, which is doubled by mild heat treatment of rbPrP", "text_with_entity_marker": "With regard to [E1]CK2[/E1], phosphorylation occurs at Ser 154 with a stoichiometry of about 0.1 mol phosphate/mol rbPrP, which is doubled by mild heat treatment of [E2]rbPrP[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CK2", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "rbPrP", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d156.s373_IEPA.d156.s373.p0", "text": "Leptin is a satiety factor which acts within the hypothalamus to decrease the levels of several neuropeptides stimulating food intake (among them, neuropeptide Y [NPY]), while increasing those that inhibit food intake", "text_with_entity_marker": "[E1]Leptin[/E1] is a satiety factor which acts within the hypothalamus to decrease the levels of several neuropeptides stimulating food intake (among them, [E2]neuropeptide Y[/E2] [NPY]), while increasing those that inhibit food intake", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "neuropeptide Y", "entity_2_idx": [[147, 161]], "entity_2_idx_in_text_with_entity_marker": [160, 174], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d158.s378_IEPA.d158.s378.p0", "text": "Many studies have indicated that neuropeptide Y (NPY) stimulates and leptin inhibits food intake", "text_with_entity_marker": "Many studies have indicated that [E1]neuropeptide Y[/E1] (NPY) stimulates and [E2]leptin[/E2] inhibits food intake", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "neuropeptide Y", "entity_1_idx": [[33, 47]], "entity_1_idx_in_text_with_entity_marker": [37, 51], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[69, 75]], "entity_2_idx_in_text_with_entity_marker": [82, 88], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d158.s379_IEPA.d158.s379.p0", "text": "In line with this, intracerebroventricular injection of NPY (10 microg) stimulated and leptin (10 microg) inhibited intake of a sucrose solution when female rats were required to obtain the solution from a bottle", "text_with_entity_marker": "In line with this, intracerebroventricular injection of [E1]NPY[/E1] (10 microg) stimulated and [E2]leptin[/E2] (10 microg) inhibited intake of a sucrose solution when female rats were required to obtain the solution from a bottle", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NPY", "entity_1_idx": [[56, 59]], "entity_1_idx_in_text_with_entity_marker": [60, 63], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[87, 93]], "entity_2_idx_in_text_with_entity_marker": [100, 106], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s386_IEPA.d161.s386.p2", "text": "Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion", "text_with_entity_marker": "Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, [E1]uncoupling proteins 2[/E1] and [E2]3[/E2], and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "uncoupling proteins 2", "entity_1_idx": [[101, 122]], "entity_1_idx_in_text_with_entity_marker": [105, 126], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "3", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s389_IEPA.d161.s389.p2", "text": "These data suggest that the in vivo gene expression of FAT/CD36, PPAR-gamma2, leptin, UCP-2, UCP-3, and TNF-alpha in subcutaneous adipose tissue is regulated by circulating lipids independent of insulin and that prolonged hyperlipidemia may therefore contribute to increased fat metabolism and storage as a result of the increased expression of these proteins", "text_with_entity_marker": "These data suggest that the in vivo gene expression of FAT/CD36, PPAR-gamma2, leptin, [E1]UCP-2[/E1], [E2]UCP-3[/E2], and TNF-alpha in subcutaneous adipose tissue is regulated by circulating lipids independent of insulin and that prolonged hyperlipidemia may therefore contribute to increased fat metabolism and storage as a result of the increased expression of these proteins", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP-2", "entity_1_idx": [[86, 91]], "entity_1_idx_in_text_with_entity_marker": [90, 95], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[93, 98]], "entity_2_idx_in_text_with_entity_marker": [106, 111], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d162.s392_IEPA.d162.s392.p0", "text": "We examined daily food consumption, body weight, whole-body oxygen consumption, serum leptin, and NPY mRNA in the hypothalamus", "text_with_entity_marker": "We examined daily food consumption, body weight, whole-body oxygen consumption, serum [E1]leptin[/E1], and [E2]NPY[/E2] mRNA in the hypothalamus", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[86, 92]], "entity_1_idx_in_text_with_entity_marker": [90, 96], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[98, 101]], "entity_2_idx_in_text_with_entity_marker": [111, 114], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d162.s393_IEPA.d162.s393.p0", "text": "Leptin infusion diminished hypothalamic NPY levels by nearly 50% compared with pair-fed young rats, whereas there were no changes in the hypothalamic NPY mRNA levels in senescent rats", "text_with_entity_marker": "[E1]Leptin[/E1] infusion diminished hypothalamic [E2]NPY[/E2] levels by nearly 50% compared with pair-fed young rats, whereas there were no changes in the hypothalamic NPY mRNA levels in senescent rats", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[40, 43]], "entity_2_idx_in_text_with_entity_marker": [53, 56], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d165.s398_IEPA.d165.s398.p0", "text": "The aim of the current investigations was focused on the study of the involvement of leptin and neuropeptide Y in lipid mobilization", "text_with_entity_marker": "The aim of the current investigations was focused on the study of the involvement of [E1]leptin[/E1] and [E2]neuropeptide Y[/E2] in lipid mobilization", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[85, 91]], "entity_1_idx_in_text_with_entity_marker": [89, 95], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "neuropeptide Y", "entity_2_idx": [[96, 110]], "entity_2_idx_in_text_with_entity_marker": [109, 123], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d168.s408_IEPA.d168.s408.p0", "text": "These results suggest that central leptin stimulates T3 production via an activation of T4 to T3 conversion, and that this stimulation could be responsible for the effect of leptin on muscle UCP-3 expression", "text_with_entity_marker": "These results suggest that central [E1]leptin[/E1] stimulates T3 production via an activation of T4 to T3 conversion, and that this stimulation could be responsible for the effect of [E2]leptin[/E2] on muscle UCP-3 expression", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[35, 41]], "entity_1_idx_in_text_with_entity_marker": [39, 45], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[174, 180]], "entity_2_idx_in_text_with_entity_marker": [187, 193], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d172.s416_IEPA.d172.s416.p0", "text": "Therefore, it was examined whether stimulation of Swiss 3T3 cells with insulin causes changes in the subcellular distribution of EGF receptors and phospholipase Cgamma1 that could potentially explain the observed synergy or costimulation.", "text_with_entity_marker": "Therefore, it was examined whether stimulation of Swiss 3T3 cells with [E1]insulin[/E1] causes changes in the subcellular distribution of EGF receptors and [E2]phospholipase Cgamma1[/E2] that could potentially explain the observed synergy or costimulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[71, 78]], "entity_1_idx_in_text_with_entity_marker": [75, 82], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase Cgamma1", "entity_2_idx": [[147, 168]], "entity_2_idx_in_text_with_entity_marker": [160, 181], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d172.s417_IEPA.d172.s417.p0", "text": "However, both EGF and insulin stimulated the accumulation of phospholipase Cgamma1 at the actin arc, which was coincident with the EGF receptor in the case of insulin- stimulated cells.", "text_with_entity_marker": "However, both EGF and [E1]insulin[/E1] stimulated the accumulation of [E2]phospholipase Cgamma1[/E2] at the actin arc, which was coincident with the EGF receptor in the case of insulin- stimulated cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[22, 29]], "entity_1_idx_in_text_with_entity_marker": [26, 33], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase Cgamma1", "entity_2_idx": [[61, 82]], "entity_2_idx_in_text_with_entity_marker": [74, 95], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d172.s417_IEPA.d172.s417.p2", "text": "However, both EGF and insulin stimulated the accumulation of phospholipase Cgamma1 at the actin arc, which was coincident with the EGF receptor in the case of insulin- stimulated cells.", "text_with_entity_marker": "However, both EGF and insulin stimulated the accumulation of [E1]phospholipase Cgamma1[/E1] at the actin arc, which was coincident with the EGF receptor in the case of [E2]insulin[/E2]- stimulated cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phospholipase Cgamma1", "entity_1_idx": [[61, 82]], "entity_1_idx_in_text_with_entity_marker": [65, 86], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[159, 166]], "entity_2_idx_in_text_with_entity_marker": [172, 179], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d174.s423_IEPA.d174.s423.p2", "text": "The total intake of flavonoids was inversely correlated with the plasma total cholesterol concentration (TC) (r = -0.236, P: < 0.05) and plasma LDL cholesterol concentration (LDL-C) (r = -0.220, P: < 0.05), after the adjustment for age, body mass index and total energy intake", "text_with_entity_marker": "The total intake of flavonoids was inversely correlated with the plasma total [E1]cholesterol[/E1] concentration (TC) (r = -0.236, P: < 0.05) and plasma LDL [E2]cholesterol[/E2] concentration (LDL-C) (r = -0.220, P: < 0.05), after the adjustment for age, body mass index and total energy intake", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cholesterol", "entity_1_idx": [[78, 89]], "entity_1_idx_in_text_with_entity_marker": [82, 93], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "cholesterol", "entity_2_idx": [[148, 159]], "entity_2_idx_in_text_with_entity_marker": [161, 172], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d177.s428_IEPA.d177.s428.p0", "text": "These results demonstrate that chronic central infusion to produce a persistent elevation of the cytokine at pathophysiological levels (a situation that may normally manifest during infection, injury and inflammation) produced severe anorexia and weight loss in conjunction with reduction in both serum leptin concentrations and hypothalamic NPY gene expression", "text_with_entity_marker": "These results demonstrate that chronic central infusion to produce a persistent elevation of the cytokine at pathophysiological levels (a situation that may normally manifest during infection, injury and inflammation) produced severe anorexia and weight loss in conjunction with reduction in both serum [E1]leptin[/E1] concentrations and hypothalamic [E2]NPY[/E2] gene expression", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[303, 309]], "entity_1_idx_in_text_with_entity_marker": [307, 313], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[342, 345]], "entity_2_idx_in_text_with_entity_marker": [355, 358], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d178.s429_IEPA.d178.s429.p0", "text": "A caveolin-1-dependent coupling of PrPc to the tyrosine kinase Fyn was observed", "text_with_entity_marker": "A caveolin-1-dependent coupling of [E1]PrPc[/E1] to the [E2]tyrosine kinase Fyn[/E2] was observed", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PrPc", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "tyrosine kinase Fyn", "entity_2_idx": [[47, 66]], "entity_2_idx_in_text_with_entity_marker": [60, 79], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d183.s440_IEPA.d183.s440.p0", "text": "Our results, ie higher mean plasma NPY levels in postmenopausal diabetic women and positive correlation of CCK with leptin and insulin, may suggest the role of these neuropeptides in metabolic disorders leading to type 2 diabetes mellitus", "text_with_entity_marker": "Our results, ie higher mean plasma [E1]NPY[/E1] levels in postmenopausal diabetic women and positive correlation of CCK with [E2]leptin[/E2] and insulin, may suggest the role of these neuropeptides in metabolic disorders leading to type 2 diabetes mellitus", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NPY", "entity_1_idx": [[35, 38]], "entity_1_idx_in_text_with_entity_marker": [39, 42], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[116, 122]], "entity_2_idx_in_text_with_entity_marker": [129, 135], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d186.s444_IEPA.d186.s444.p0", "text": "Insulin secretion, inositol phosphate levels, and phospholipase C isozymes in rodent pancreatic islets", "text_with_entity_marker": "[E1]Insulin[/E1] secretion, inositol phosphate levels, and [E2]phospholipase C[/E2] isozymes in rodent pancreatic islets", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Insulin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[50, 65]], "entity_2_idx_in_text_with_entity_marker": [63, 78], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d190.s456_IEPA.d190.s456.p0", "text": "We aimed at studying the effects of leptin, CART and NPY on the hypothalamic control of the pituitary-gonadal system.", "text_with_entity_marker": "We aimed at studying the effects of [E1]leptin[/E1], CART and [E2]NPY[/E2] on the hypothalamic control of the pituitary-gonadal system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[36, 42]], "entity_1_idx_in_text_with_entity_marker": [40, 46], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[53, 56]], "entity_2_idx_in_text_with_entity_marker": [66, 69], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d194.s466_IEPA.d194.s466.p1", "text": "Co-expression of PLD1 with phospholipase C (PLC)gamma has the same effect, while co-expression of PLD2 with PLCgamma allows PLD2 activity to be stimulated in an insulin-dependent manner.", "text_with_entity_marker": "Co-expression of PLD1 with [E1]phospholipase C (PLC)gamma[/E1] has the same effect, while co-expression of PLD2 with PLCgamma allows PLD2 activity to be stimulated in an [E2]insulin[/E2]-dependent manner.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phospholipase C (PLC)gamma", "entity_1_idx": [[27, 53]], "entity_1_idx_in_text_with_entity_marker": [31, 57], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[161, 168]], "entity_2_idx_in_text_with_entity_marker": [174, 181], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d195.s474_IEPA.d195.s474.p0", "text": "Within 20 min after exposure to leptin, NPY secretion from hypothalamic preparations obtained from adrenalectomized mice was lowered by 27% and CRH secretion was elevated by 51%", "text_with_entity_marker": "Within 20 min after exposure to [E1]leptin[/E1], [E2]NPY[/E2] secretion from hypothalamic preparations obtained from adrenalectomized mice was lowered by 27% and CRH secretion was elevated by 51%", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[32, 38]], "entity_1_idx_in_text_with_entity_marker": [36, 42], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[40, 43]], "entity_2_idx_in_text_with_entity_marker": [53, 56], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d196.s476_IEPA.d196.s476.p0", "text": "Both receive information about the nutritional status and the level of energy storage through insulin and leptin signaling mediated by specific receptors located on POMC and NPY neurons present predominantly in the arcuate nucleus (ARC).", "text_with_entity_marker": "Both receive information about the nutritional status and the level of energy storage through insulin and [E1]leptin[/E1] signaling mediated by specific receptors located on POMC and [E2]NPY[/E2] neurons present predominantly in the arcuate nucleus (ARC).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[106, 112]], "entity_1_idx_in_text_with_entity_marker": [110, 116], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[174, 177]], "entity_2_idx_in_text_with_entity_marker": [187, 190], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
